# Energy for the Brain

> **NCT03132233** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 42 (actual)

## Conditions studied

- Migraine
- Episodic Migraine

## Interventions

- **DIETARY_SUPPLEMENT:** Beta-hydroxybutyrate calcium and magnesium salt
- **OTHER:** placebo powder

## Key facts

- **NCT ID:** NCT03132233
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2020-01-16
- **Final completion:** 2020-01-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132233, "Energy for the Brain". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03132233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*